A Message From The President
Rudy Nuijts
Published: Monday, March 30, 2020
Dear Colleagues
As we begin another week of the COVID - 19 challenge we bring you news on some of the work that is being done around the world to develop treatment for and vaccines to prevent this most awful disease.
It is encouraging to know that so many different scientists, universities and commercial groups are working together to find solutions. At the same time, we are cautioned that even with Artificial Intelligence assistance and advanced computer modelling a vaccine before the middle of 2021 will not be possible even with considerable investment and funding.
We are continuing to communicate with our friends and colleagues across Europe and later this week will have updates from Germany, Austria and Spain.
Please stay safe and well.
Rudy Nuijts
Rudy Nuijts
Prof. dr Rudy MMA Nuijts
ESCRS President
Tags: covid-19 uk
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.